Phase 2 Short Stature Clinical Trials
4 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–4 of 4 trials
Recruiting
Phase 2
A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature
Idiopathic Short Stature
BioMarin Pharmaceutical100 enrolled47 locationsNCT06382155
Recruiting
Phase 2
A Basket Study of Vosoritide in Children With Turner Syndrome, Short Stature Homeobox-Containing Gene Deficiency, and Noonan Syndrome With Inadequate Growth During or After Human Growth Hormone Treatment
Noonan SyndromeTurner SyndromeShort Stature Homeobox- Containing Gene SHOX Deficiency
BioMarin Pharmaceutical54 enrolled24 locationsNCT06668805
Recruiting
Phase 2
A Phase II Study of PEG-rhGH Injection for Short Children Born Small for Gestational Age: Efficacy, Safety, and Pharmacokinetics
Short Stature Children Born Small for Gestational Age (SGA)
Changchun GeneScience Pharmaceutical Co., Ltd.72 enrolled1 locationNCT07260500
Recruiting
Phase 2
Vosoritide for Short Stature in Turner Syndrome
Turner SyndromeShort Stature
Roopa Kanakatti Shankar, MBBS, MS20 enrolled1 locationNCT05849389